Karolinska Institutet Science Park DAY
Stockholm 2011
Welcome to Karolinska Institutet Science Park DAY Stockholm 2011
For the 2nd year running Karolinska Institutet Science Park is hosting this conference to present novel innovations and projects from the park. New this year is that we have partnered with Globe Forum which will offer the possibility to meet prospective collaborators and enhance the chance of finding breakthrough solutions that will drive future business growth.
| Date: |
May 11, 2011 |
| Place: |
Stockholm Waterfront Congress Centre |
Program
Moderator: Fredrik Röök, Karolinska Development AB
| Time |
Topic |
|
10:00 - 10:10 |
Opening Session
Karolinska Institutet Science Park AB, Märit Johansson |
|
10:10 - 11:00 |
Session 1 - Novel innovations and projects
APR-246 – a novel anticancer compound targeting p53 with unique features currently in clinical development
Aprea AB, Charlotta Liljebris
AXL1717 - a new treatment for cancer
Axelar AB, Birgitta Ståhl
New technologies for cancer management
NeoDynamics AB, Kai-Uwe Schässburger
Is there use for a new improved alkylating agent in the treatment of cancer?
Oncopeptides AB, Jack Spira
Green manufacturing of nanoparticles offer benefits for anti-cancer applications
XSpray Microparticles AB, Per Andersson |
|
11:00 - 11:30 |
Coffee & Networking |
|
11:30 - 12:00 |
Globe Forum Innovators' Contest |
|
12:10 - 13:00 |
Session 2 - Novel Innovation and Projects
Accelerated drug development by crystal re-engineering: the case of axp 107-11
Axcentua Pharmaceuticals AB,Stefan Rehnmark
Tafoxiparin, a novel treatment against complicated and protracted labor. An opportunity for women around the world
Dilafor AB, Lena Degling Wikingsson
The wound healing heparin-chitosan complex for treatment of inflammatory and infectious disorders
ExThera AB, Olle Larm
Silencing inflammation
NovaSAID AB, Pirkko Sulila Tamsen
Tissue access by endovascular technique
The Extroducer, Staffan Holmin |
|
13:00 - 14:00 |
Lunch & Networking |
|
14:00 - 14:30 |
Session 3 - Investors
Do's and don'ts when dealing with Big Pharma
Abbott Scandinavia AB, Anna Levander
Your first meeting with the ”Dark Side” i.e. the venture capitalist SEED Capital Denmark, Carsten Schou |
|
14:30 - 14:40 |
Closing
Karolinska Institutet Innovations AB, Lilian Wikström |
|
14:45 - 15:00 |
Globe Forum Innovators' Contest, Prize Ceremony |